KMS Medisurgi Limited (BOM:540468)
India · Delayed Price · Currency is INR 126.50
0.00 (0.00%)
At close: Sep 16, 2025
KMS Medisurgi Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Operating Revenue | 127.41 | 139.39 | 138.85 | 110.27 | 103.17 | 75.1 |
Other Revenue | - | - | - | -0 | - | - |
| 127.41 | 139.39 | 138.85 | 110.27 | 103.17 | 75.1 | |
Revenue Growth (YoY) | -12.41% | 0.39% | 25.91% | 6.88% | 37.38% | -27.40% |
Cost of Revenue | 95.41 | 107.68 | 108.7 | 80 | 78.92 | 58.43 |
Gross Profit | 32 | 31.71 | 30.15 | 30.27 | 24.25 | 16.67 |
Selling, General & Admin | 11.61 | 11.97 | 12.39 | 10.74 | 8.86 | 6.85 |
Other Operating Expenses | 8.09 | 10.34 | 9.94 | 9.92 | 10.13 | 4.77 |
Operating Expenses | 23.05 | 24.97 | 24.83 | 23.84 | 21.9 | 14.93 |
Operating Income | 8.95 | 6.73 | 5.32 | 6.43 | 2.35 | 1.74 |
Interest Expense | -1.35 | -0.83 | -0.21 | -0 | -0.02 | -0.09 |
Interest & Investment Income | 0.11 | 0.11 | 0.08 | 0.08 | 0.13 | 0.67 |
Currency Exchange Gain (Loss) | 0.09 | 0.09 | 0.85 | - | - | 0.26 |
Other Non Operating Income (Expenses) | 0.22 | -0 | - | 0.07 | 0.38 | -0.21 |
EBT Excluding Unusual Items | 8.02 | 6.1 | 6.04 | 6.59 | 2.85 | 2.37 |
Other Unusual Items | - | - | - | - | - | -0.36 |
Pretax Income | 8.02 | 6.1 | 6.04 | 6.59 | 2.85 | 2.02 |
Income Tax Expense | 2.09 | 1.7 | 1.51 | 0.86 | 0.7 | 0.79 |
Net Income | 5.93 | 4.4 | 4.54 | 5.73 | 2.15 | 1.23 |
Net Income to Common | 5.93 | 4.4 | 4.54 | 5.73 | 2.15 | 1.23 |
Net Income Growth | - | -3.08% | -20.79% | 166.22% | 75.10% | 9.36% |
Shares Outstanding (Basic) | 3 | 3 | 3 | 3 | 3 | 3 |
Shares Outstanding (Diluted) | 3 | 3 | 3 | 3 | 3 | 3 |
Shares Change (YoY) | 0.49% | - | - | - | - | - |
EPS (Basic) | 1.79 | 1.33 | 1.38 | 1.74 | 0.65 | 0.37 |
EPS (Diluted) | 1.79 | 1.33 | 1.38 | 1.74 | 0.65 | 0.37 |
EPS Growth | - | -3.28% | -20.79% | 166.22% | 75.10% | 9.36% |
Free Cash Flow | 2.84 | -2.33 | 6.75 | -2.03 | -1.86 | 3.6 |
Free Cash Flow Per Share | 0.86 | -0.71 | 2.05 | -0.61 | -0.56 | 1.09 |
Dividend Per Share | - | 0.050 | 0.050 | 0.050 | 0.050 | 0.050 |
Gross Margin | 25.12% | 22.75% | 21.71% | 27.45% | 23.51% | 22.20% |
Operating Margin | 7.02% | 4.83% | 3.83% | 5.83% | 2.28% | 2.32% |
Profit Margin | 4.65% | 3.16% | 3.27% | 5.20% | 2.09% | 1.64% |
Free Cash Flow Margin | 2.23% | -1.67% | 4.86% | -1.84% | -1.81% | 4.79% |
EBITDA | 12.3 | 9.39 | 7.83 | 9.61 | 5.27 | 5.05 |
EBITDA Margin | 9.66% | 6.74% | 5.64% | 8.71% | 5.10% | 6.73% |
D&A For EBITDA | 3.36 | 2.66 | 2.51 | 3.18 | 2.91 | 3.31 |
EBIT | 8.95 | 6.73 | 5.32 | 6.43 | 2.35 | 1.74 |
EBIT Margin | 7.02% | 4.83% | 3.83% | 5.83% | 2.28% | 2.32% |
Effective Tax Rate | 26.11% | 27.91% | 24.91% | 13.00% | 24.54% | 39.10% |
Revenue as Reported | 127.92 | 139.67 | 139.78 | 110.43 | 103.68 | 76.06 |
Advertising Expenses | - | - | 0.01 | 0.12 | - | 0.01 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.